CooperCompanies Elects Teresa S. Madden to Board of Directors

By Staff
Thursday, November 19, 2020 12:18 AM SAN RAMON, Calif.—CooperCompanies (NYSE: COO) announced that its board of directors elected Teresa S. Madden to the board as an independent director, effective Dec. 1, 2020.

U.S. Vision Notifies New Jersey of its Plans to Lay Off Roughly 300 Workers

By Staff
Friday, November 13, 2020 12:21 AM GLENDORA, N.J.—In a recent filing  with the state of New Jersey, USV Optical Inc., which operates as U.S. Vision, said it intends to lay off 299 workers at its lab in Blackwood, N.J.

Alcon Says ‘Significant Recovery’ in Q3 Sales Improved Operating Results

By Staff
Thursday, November 12, 2020 12:27 AM GENEVA, Switzerland—Noting that it sees a “strong market recovery” underway, Alcon (SIX/NYSE:ALC) reported this week that its sales in the third quarter totaled $1.8 billion, a decrease of 1 percent on both a reported and constant currency basis. However, the company noted in an announcement late Tuesday that a significant recovery in third quarter sales helped to drive a “strong improvement in operating results” compared with 2020’s second quarter. Alcon also said that it has seen momentum in its new products PanOptix trifocal lens and Precision1 contact lenses that are “driving market share gains.”

New Look Vision Group Reports Strong Third-Quarter Results

By Staff
Tuesday, November 10, 2020 12:24 AM MONTREAL—New Look Vision Group Inc. (TSX: BCI), a leader in the Canadian retail optical industry with stores across Canada, said its third-quarter revenues rose to $86.9 million, an increase of 16.8 percent compared with the year-ago period, as comparable store sales jumped 13.5 percent in the period ended Sept. 26. The company’s adjusted EBITDA rose 140.8 percent, according to New Look Vision’s earnings announcement late last week. Among other highlights of Q3, New Look Vision said it launched new websites and iPhone applications as part of its omnichannel strategy.

National Vision Reports ‘Exceptionally Strong’ Third Quarter as Comparable-Store Sales Post Double-Digit Increases

By Staff
Friday, November 6, 2020 12:27 AM DULUTH, Ga.—National Vision Holdings Inc.(NASDAQ: EYE) reported Thursday that sales in the third quarter increased 12.4 percent to $485.4 million, driven by comparable-store sales growth of 11.6 percent (adjusted comparable-store growth of 12.4 percent). The company’s net income increased 2,860 percent to $35.3 million (which compares with net income of $1.2 million in the year-ago quarter), as adjusted EBITDA rose 89.3 percent to $88.1 million and adjusted operating income increased 160 percent to $67.7 million in the quarter ended Sept. 26, 2020.

Bausch Health Says Third-Quarter Sales Fall Slightly, But ‘Good Progress’ Made on Plan to Spin-Off Bausch + Lomb

By Staff
Thursday, November 5, 2020 12:21 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) this week reported that its third-quarter revenues totaled $2.138 billion, a decline of 3 percent (or $71 million) compared with revenues of $2.209 billion in the year-ago quarter.

EssilorLuxottica’s 3Q Revenue Fell 5.2 Percent Year-on-Year

By Staff
Wednesday, November 4, 2020 12:33 AM CHARENTON-LE-PONT, France—EssilorLuxottica (Reuters: ESLX.PA) yesterday reported consolidated revenue of €4,085 million for the third quarter of 2020 ending Sept. 30, representing a year-on-year decline of 5.2 percent, or -1.1 percent at constant exchange rates. The performance highlighted a strong sequential recovery compared to the second quarter of 2020, when EssilorLuxottica’s revenue was significantly impacted by the COVID-19 pandemic.

GrandVision Posts Record Adjusted EBITA in Q3

By Staff
Monday, November 2, 2020 12:30 AM SCHIPHOL, the Netherlands—GrandVision N.V. (Euronext: GVNV) reported Friday that its revenue grew by 2.3 percent at constant exchange rates to €1,047 million in the third quarter as the company’s store network fully reopened. The comparable revenue growth was 0.8 percent in the quarter, led by a strong performance in the G4 (Brazil, Germany, India, and Japan) of 3.4 percent.

Bausch Health to Reduce Debt By $150 Million Using Cash Generated From Operations

By Staff
Friday, October 30, 2020 12:12 AM LAVAL, Quebec—Bausch Health Companies Inc. (NYSE/TSX: BHC) announced this week that on Nov. 30, 2020, it will redeem approximately $100 million aggregate principal amount of its outstanding 5.875% senior notes due 2023, representing the entire outstanding amount of the 5.875% notes and approximately $50 million aggregate principal amount of its outstanding 5.50% senior notes due 2023. The redemptions will be accomplished by using cash generated from operations, according to the announcement. In August, Bausch Health announced that it plans to spin off its Bausch + Lomb eye health business into an independent publicly traded entity separate from the remainder of Bausch Health, as VMAIL reported. 

NovaBay Pharmaceuticals Regains Compliance With NYSE American Listing Standards

By Staff
Thursday, October 15, 2020 12:18 AM EMERYVILLE, Calif.—NovaBay Pharmaceuticals (NYSE American: NBY) announced it believes that it has regained full compliance with the NYSE American’s continued listing standards, subject to NYSE American’s formal confirmation.

Johnson & Johnson Reports Sales, Earnings Gains in Q3 and Expects ‘Strong Momentum Entering into 2021’

By Staff
Wednesday, October 14, 2020 12:18 AM NEW BRUNSWICK, N.J.—Johnson & Johnson  (NYSE: JNJ) reported Tuesday that both its sales and earnings increased in the third quarter, and the company noted that due to “positive trends” across its diverse health care businesses, it is raising its full-year sales guidance by $1 billion and earnings by 15 cents per share.

Safilo Group Issues COVID-19 Pandemic Business Update, Forecasts Return to Profit in Third Fiscal Quarter

By Staff
Friday, October 2, 2020 12:33 AM PADUA Italy—Safilo Group (Reuters SFLG.MI) issued a statement yesterday about the results of its third financial quarter and said "based on the business rebound recorded in July, its performance in August and preliminary data for the month of September, the Group’s management expects total net sales (including acquisitions) for the third quarter 2020 to grow mid-single digit at constant exchange rates compared to the same quarter of the previous year. The positive trend in total sales also supports the forecast for the quarter to return to a profit at the adjusted EBITDA level."

National Vision Opens 1,200th Store in Florida

By Staff
Thursday, October 1, 2020 12:33 AM DULUTH, Ga.—National Vision Holdings Inc. (NASDAQ: EYE) hit a milestone late last month with the opening of its 1,200th optical location. The new store in Deerfield Beach, Fla. operates under the America’s Best Contacts & Eyeglasses banner, a store group that represents almost two-thirds of the company’s aggregate volume. America’s Best operates more than 750 stores across 32 states, according to a recent company presentation. “In the 15 years since we bought America’s Best and the 11 years since we bought Eyeglass World we have opened hundreds of new stores,” chief executive officer Reade Fahs told VMAIL in a note.

Bausch Health to Acquire Option to Purchase Assets of Allegro Ophthalmics

By Staff
Tuesday, September 22, 2020 12:27 AM LAVAL, Quebec and SAN JUAN CAPISTRANO, Calif.— Bausch Health Companies and Bausch + Lomb, its leading global eye health business, and Allegro Ophthalmics LLC,  a privately held biopharmaceutical company, announced Monday that Bausch Health (through its affiliate) has entered into an agreement to acquire an option to purchase all ophthalmology assets of Allegro.

Santen to Acquire Topical Ophthalmic Products Company Eyevance for $225 Million Under Terms of Share Purchase Agreement

By Staff
Tuesday, September 22, 2020 12:24 AM OSAKA, Japan and FORT WORTH, Texas—Santen Pharmaceutical Co. Ltd.and Eyevance Holdings have announced that Santen Holdings U.S. Inc., a wholly-owned subsidiary of Santen, and Eyevance Holdings entered into a share purchase agreement where Santen Holdings acquires all of the outstanding shares of Eyevance Pharmaceuticals Holdings.